Key market opportunities include advancements in research, medicine, diagnostics, and biotechnology through CRISPR. There is potential for innovative solutions and ethical exploration in gene editing, ...

Simulations Plus (NASDAQ:SLP) reports strong quarterly results as Nasdaq Index tracks tech healthcare software activity.

The global metabolomics market is witnessing steady expansion driven by rising demand for precision medicine, biomarker ...

(Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for ...

Pendulum Therapeutics, a biotechnology company pioneering microbiome science to transform human health, today announced an expanded clinical research collaboration with Mayo Clinic to explore new ...

The Chinese biotechnology company submitted regulatory paperwork seeking approval for trastuzumab pamirtecan treating ...

Avaí Bio (OTCQB: AVAI) and its joint venture partner Austrianova announced on April 7, 2026, that they will present their ...

BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Dapagliflozin Tablets, 5 mg and 10 mg, in the United States following the approval for its Abbreviated ...

Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologiesSUZHOU, China and BOSTON, /PRNewswire/ -- Vivatides Therapeutics, a global biotechnology company ...

"We are executing with urgency and purpose as we advance our pipeline assets to the clinic as expeditiously as possible," said Rick Pierce, Chief Executive Officer of Decoy Therapeutics. "We are ...

The EIC has announced €118 million in funding for 30 research projects under its 2025 EIC Pathfinder Challenges call ...

Rheon Labs expands reactive polymer tech with Decathlon while Hyosung scales sugarcane-based spandex and Interspace leans ...